Cobre_Miner
Posted - 11/12/24
@docholliday22 @History101 have to agree …. It makes more sense for $BMY to step up and establish a partnership, at least, to gain a lion’s share of the schizophrenia market for the next decade.
$ABBV is reeling from their mistake with $CERE …
Cobre_Miner
Posted - 11/11/24
@Princessofdoom you are right $CERE was a SCAM!
Poor $ABBV should had made a deal with $RVPH
betachaser
Posted - 11/11/24
$VKTX ridiculous price action but not surprising given this is clinical stage biotech. Conservatively, $2 billion VK2809, $1 billion in cash, so this is being given roughly $3 billion for VK2735 which is best in class SC & Oral for Obesity. Boggles the mind how BP spent so much on garbage acquisitions like $cere and $sgen yet haven’t pounced on something as game changing as this yet.
Pika_Capital
Posted - 11/11/24
$ABBV $CERE
$8b down the drain lol 🤡 Should have bought $NBIX for $15-20B
Trading_Angels
Posted - 1 month ago
Super trends BIOtechs 2025: Upstream Bio ($UPB) clinical-stage biotechnology company developing treatments for inflammatory diseases, focus on severe respiratory disorders. Its lead product, verekitug, targets the TSLP receptor, addressing a significant unmet medical need. The experienced management team and substantial financial backing position Upstream Bio favorably for future growth. Intellia Therapeutics ($NTLA) Pioneering CRISPR/Cas9-based gene-editing therapies. Outlook: promising clinical data suggest significant potential in treating genetic diseases. Cerevel Therapeutics ($CERE) Developing therapies for central nervous system disorders, including Parkinson's, epilepsy, and schizophrenia. Sufficient cash reserves, positioned for potential upside by 2025. Vertex Pharmaceuticals ($VRTX) Focus: Specializes in treatments for cystic fibrosis and is expanding into gene-editing therapies, robust pipeline and strategic collaborations.
NoRisksNoFun
Posted - 1 month ago
$ARKG but $SNTI $CERE are deep in red!
quickaspeter
Posted - 10/22/24
@TradingtooRetire @Idvst8 I believe $IOVA is little over 5% of their portfolio, while $CERE is their top holding.
anesthesia_sleep
Posted - 09/12/24
$NKGN Today announced POSITIVE phase 1 Data in Alzheimer’s Disease! NKGen’s cryopreserved autologous enhanced NK cell therapy for the treatment of moderate Alzheimer’s disease
Here are the billion dollar Alzheimer’s companies: $BIIB with LEQEMBI
$ITCI with Intra-Cellular Therapies for treating psychosis in Alzheimer’s $CERE hallucinations and delusions associated with Alzheimer's disease psychosis
willdenton331
Posted - 08/27/24
$CERE thank you for a nice ride
SaintJeremiah
Posted - 08/14/24
$ABBV $CERE $MRNA 1000% upside & undervalued pulled back to the point of a gap up or squeeze, recently received fast track for pancreatic cancer
DLBEE
Posted - 08/09/24
@Nochtar Abbvie just bought $CERE for $45 a share on July 31 2024.
G101SPM
Posted - 08/08/24
$ABBV $CERE $45.00. TAKE PROFIT DAC (dollar average cost) $41.90 (4.18.24) PRINT 8.1.24 AbbVie announced that it has completed its acquisition of Cerevel Therapeutics $CERE. note: In December 2023, the companies signed a definitive agreement under which AbbVie agreed to acquire Cerevel for $45 per share in cash.
BottomFishers
Posted - 4 months ago
$KTTA Bears are getting forced out by EoD🔥 $VALE $CERE $SWN.DL1024 $SWIN
Stock_Titan
Posted - 4 months ago
$ABBV $CERE AbbVie Completes Acquisition of Cerevel Therapeutics
https://www.stocktitan.net/news/ABBV/abb-vie-completes-acquisition-of-cerevel-f0y604h738kk.html
tradingcalendar
Posted - 07/31/24
Cerevel Therapeutics $CERE being acquired by AbbVie $ABBV - Shares of CERE to be delisted tonight after 8PM ET - Shareholders to receive $45.00 cash per share More information : https://www.sec.gov/Archives/edgar/data/1805387/000119312523290342/d509048ddefa14a.htm
tradethehalt
Posted - 07/31/24
$CERE trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $44.97 Vol: 15.04M.
jbraun123
Posted - 07/31/24
$CERE Per DTC, expect payout to happen tmrw :) GLTA
NVDAMillionaire
Posted - 07/30/24
$CERE Cerevel Therapeutics Holdings, Inc. (CERE): A Promising Neuroscience Powerhouse Poised for Transformative Growth http://beyondspx.com/2024/07/30/cerevel-therapeutics-holdings-inc-cere-a-promising-neuroscience-powerhouse-poised-for-transformative-growth/
flytrader1
Posted - 07/26/24
$CERE No news for months except for the FCC scare recently. They will release earnings shortly which most likely explains the rebound in price as the market anticipates that the deal will close in weeks.
paiocje
Posted - 07/18/24
$CERE Why is pre-market on YF and stocktwits showing $44 but IBKR says no change from close?
paiocje
Posted - 07/16/24
$CERE Is anyone actually active on this board? Remarkably quiet vs deals like SGEN
gentleowl
Posted - 07/15/24
$CERE tomorrow 43$
TickerDD_com
Posted - 5 months ago
From 6/17/2024, looking back across 21 Month-Ends for CERE, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $CERE #CERE #CEREStock #TickerDD #CEREPrice https://www.youtube.com/watch?v=VerL56oiKjI
PeedyWeedy
Posted - 06/29/24
$CERE Is there an upcoming data release for darigabat, if so, when it is expected? Thanks.
KCSVEN
Posted - 06/26/24
$CERE According to a Seeking Alpha article: "While there was no specific reason for the drop on Tuesday, some traders told Seeking Alpha there was some vague speculation out of unidentified broker that the FTC was gearing up for a lawsuit and that Cerevel (CERE) was increasingly looking like it may be the target for the regulator. Some people also attributed the weakness to the Russell index reconstitution on Friday and some options trades on Tuesday."
OpenOutcrier
Posted - 06/25/24
RECAP 6/25 Unusual Puts: $CERE Aug 40/35 P Spd $LW Aug 75 P Live Breaking trading news www.openoutcrier.com
KCSVEN
Posted - 06/25/24
$CERE FROM YAHOO BOARD Abbvie had their Parkinson’s drug turned down by the FDA today because they did not like what they found at the manufacturing plant run by a third-party unrelated company. The FDA said there are no issues at all with the actual drug and they are not making any requests for new studies or information about the drug, but yes, it could delay drug approval. people are probably worried that it will delay CERE’s drug as well, and if this would be considered a MAC that would allow abbvie to cancel the deal. Read the Delaware contract and you will see that that is not a MAC, even if they wanted out of the deal, and they do not. The contract specifies that drug approval is NOT a MAC, thus abbvie assumes all risk. This is simply people getting afraid, but they will quickly realize there’s no reason. Take advantage of it and buy some now. Even if the actual manufacturing and drug approval is delayed it has nothing to do with the timing of the buyout being finalized.
TeresaTrades
Posted - 06/25/24
Heavy options volume $PTEN $ITB $BMBL $CERE $FYBR
flytrader1
Posted - 06/25/24
$CERE lots of bearish option action & implied volatility has jumped
KCSVEN
Posted - 06/25/24
$CERE Not good this close to when a close should be happening to be down 5% on heavy volume with a Bearish Put Spread put on right before the move. "Could" be a bear raid but also could be a sign some negative news is coming, best to be on sidelines and see what happens.